UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054900
Receipt number R000062721
Scientific Title Central arterial waveform and blood pressure change during hemodialysis
Date of disclosure of the study information 2024/07/08
Last modified on 2025/07/09 12:15:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Central arterial waveform and blood pressure change during hemodialysis

Acronym

Central arterial waveform and blood pressure change during hemodialysis

Scientific Title

Central arterial waveform and blood pressure change during hemodialysis

Scientific Title:Acronym

Central arterial waveform and blood pressure change during hemodialysis

Region

Japan


Condition

Condition

chronic kidney disease patients requiring regular hemodialysis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examination of whether assessment of the arterial waveform has clinical implications for the management of regular hemodialysis patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood pressure levels

Key secondary outcomes

Prognosis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Chronic kidney patients aged >18 years and received thrice-weekly maintenance hemodialysis

Key exclusion criteria

(i) nonsinus rhythm
(ii) old nonfunctional fistula on the contralateral arm from that currently used for dialysis access
(iii) Stage III.IV congestive heart failure, according to New York Heart Association classification
(iv) life expectancy of less than one year
(v) apparent infection
(vi) myocardial infarction and/or stroke within 30 days
(vii) current pregnancy
(viii) malignancy

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Toshihiko
Middle name
Last name Ishimitsu

Organization

Utsunomiya Central Hospital

Division name

Department of Internal Medicine

Zip code

321-0953

Address

2-1-1, Higashi-shukugou, Utsunomiya city, Tochigi, Japan

TEL

0286351110

Email

t-ishimitsu@sun.ucatv.ne.jp


Public contact

Name of contact person

1st name Yoshio
Middle name
Last name Iwashima

Organization

Kansai Medical University Kori Hospital

Division name

Department of Internal Medicine

Zip code

572-8551

Address

8-45 Kori Hon-douri chou, Neyagawa city, Osaka, Japan

TEL

0728325321

Homepage URL


Email

iwashima@geriat.med.osaka-u.ac.jp


Sponsor or person

Institute

Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gotebnyama Hospital

Address

1682-2, Shin-imamiya-chou, Kanuma city, Tochigi, Japan

Tel

0289642131

Email

touseki@gotenyama.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

400

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 03 Month 03 Day

Date of IRB

2020 Year 03 Month 18 Day

Anticipated trial start date

2020 Year 05 Month 10 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Recording of dialysis treatment and measurements of hemodynamic parameters were performed on two consecutive dialysis days by using commercially available software (SphygmoCor XCEL; AtCor Medical, Sydney, Australia). Measurements were performed immediately before the start of hemodialysis after five minutes in the supine position, every 30 minutes during dialysis, and just before detachment of the dialysis circuit from the patient.


Management information

Registered date

2024 Year 07 Month 06 Day

Last modified on

2025 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062721